메뉴 건너뛰기




Volumn 26, Issue 1, 2013, Pages 45-51

Herpes zoster knowledge, prevalence, vaccination rate by race

Author keywords

Elderly; Health services for the aged; Herpes zoster; Immunization; Public health; Vaccination

Indexed keywords

VARICELLA ZOSTER VACCINE;

EID: 84872254447     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2013.01.120154     Document Type: Article
Times cited : (45)

References (21)
  • 2
    • 21144448596 scopus 로고    scopus 로고
    • A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
    • Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271-84.
    • (2005) N Engl J Med , vol.352 , pp. 2271-2284
    • Oxman, M.N.1    Levin, M.J.2    Johnson, G.R.3
  • 3
    • 20444420834 scopus 로고    scopus 로고
    • Incidence of herpes zoster, before and after varicella-vaccination- associated decreases in the incidence of varicella, 1992-2002
    • DOI 10.1086/430325
    • Jumaan AO, Yu O, Jackson LA, et al. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis 2005;191:2002-7. (Pubitemid 40800569)
    • (2005) Journal of Infectious Diseases , vol.191 , Issue.12 , pp. 2002-2007
    • Jumaan, A.O.1    Yu, O.2    Jackson, L.A.3    Bohlke, K.4    Galil, K.5    Seward, J.F.6
  • 5
    • 0028920560 scopus 로고
    • Racial differences in the occurrence of herpes zoster
    • Schmader K, George LK, Burchett BM, et al. Racial differences in the occurrence of herpes zoster. J Infect Dis 1995;171:701-4.
    • (1995) J Infect Dis , vol.171 , pp. 701-704
    • Schmader, K.1    George, L.K.2    Burchett, B.M.3
  • 6
    • 34047263785 scopus 로고    scopus 로고
    • Chicken-pox exposure and herpes zoster disease incidence in older adults in the U.S
    • Chaves SS, Santibanez TA, Gargiullo P, et al. Chicken-pox exposure and herpes zoster disease incidence in older adults in the U.S. Public Health Rep 2007; 122:155-9.
    • (2007) Public Health Rep , vol.122 , pp. 155-159
    • Chaves, S.S.1    Santibanez, T.A.2    Gargiullo, P.3
  • 9
    • 35848954757 scopus 로고    scopus 로고
    • A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction
    • Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007;82:1341-9. (Pubitemid 350060129)
    • (2007) Mayo Clinic Proceedings , vol.82 , Issue.11 , pp. 1341-1349
    • Yawn, B.P.1    Saddier, P.2    Wollan, P.C.3    St., S.J.L.4    Kurland, M.J.5    Sy, L.S.6
  • 10
    • 44849103815 scopus 로고    scopus 로고
    • Prevention of herpes zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    • Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC) quiz CE32-34
    • Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008;57: 1-30; quiz CE32-34.
    • (2008) MMWR Recomm Rep , vol.57 , pp. 1-30
    • Harpaz, R.1    Ortega-Sanchez, I.R.2    Seward, J.F.3
  • 11
    • 85172061006 scopus 로고    scopus 로고
    • March 24, Available at: Accessed September 12, 2011
    • Sun W, US Food and Drug Administration. Approval letter - Zostavax [letter online]. March 24, 2011. Available at: www.fda.gov/ biologicsbloodvaccines/vaccines/approvedproducts/ucm248608.htm. Accessed September 12, 2011.
    • (2011) Approval Letter - Zostavax [Letter Online]
    • Sun, W.1
  • 13
    • 58249122600 scopus 로고    scopus 로고
    • Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: Uptake of the first new vaccine to target seniors
    • Lu PJ, Euler GL, Jumaan AO, et al. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors. Vaccine 2009;27:882-7.
    • (2009) Vaccine , vol.27 , pp. 882-887
    • Lu, P.J.1    Euler, G.L.2    Jumaan, A.O.3
  • 14
    • 85172056723 scopus 로고    scopus 로고
    • Rates and predictors of influenza, pneumococcal, and herpes zoster vaccination in adult patients with rheumatic diseases
    • Presented at the Available at: Accessed March 1, 2012
    • Wolf F, Michaud K. Rates and predictors of influenza, pneumococcal, and herpes zoster vaccination in adult patients with rheumatic diseases. Presented at the ACR/AHRP Scientific Meeting, October 17-21, 2009, Philadelphia, PA. Available at: http://acr. confex.com/acr/2009/webprogram/Paper10757.html. Accessed March 1, 2012.
    • ACR/AHRP Scientific Meeting, October 17-21, 2009, Philadelphia, PA
    • Wolf, F.1    Michaud, K.2
  • 15
    • 77952511170 scopus 로고    scopus 로고
    • Barriers to the use of herpes zoster vaccine
    • Hurley LP, Lindley MC, Harpaz R, et al. Barriers to the use of herpes zoster vaccine. Ann Intern Med 2010;152:555-60.
    • (2010) Ann Intern Med , vol.152 , pp. 555-560
    • Hurley, L.P.1    Lindley, M.C.2    Harpaz, R.3
  • 16
    • 33750135411 scopus 로고    scopus 로고
    • Herpes zoster vaccine (Zostavax)
    • Herpes zoster vaccine (Zostavax). Med Lett Drugs Ther 2006;48:73-4.
    • (2006) Med Lett Drugs Ther , vol.48 , pp. 73-74
  • 17
    • 78651505523 scopus 로고    scopus 로고
    • Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease
    • Tseng H, Smith N, Harpez R. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA 2011;305:160-16.
    • (2011) JAMA , vol.305 , pp. 160-216
    • Tseng, H.1    Smith, N.2    Harpez, R.3
  • 18
    • 77952526262 scopus 로고    scopus 로고
    • Safety of Herpes Zoster Vaccine in the Shingles Prevention Study: A randomized trial
    • Simberkoff M, Arbeit R, Johnson G. Safety of Herpes Zoster Vaccine in the Shingles Prevention Study: a randomized trial. Ann Intern Med 2010;152:545-54.
    • (2010) Ann Intern Med , vol.152 , pp. 545-554
    • Simberkoff, M.1    Arbeit, R.2    Johnson, G.3
  • 19
    • 85172057383 scopus 로고    scopus 로고
    • Available at: Accessed September 12, 2011
    • The Harvard Medical School Family Health Guide. The shingles vaccine: why hasn't it caught on? 2007. Available at: www.health.harvard.edu/fhg/updates/ The-shingles-vaccine.shtml. Accessed September 12, 2011.
    • (2007) The Shingles Vaccine: Why Hasn't It Caught On?
  • 20
    • 34249908675 scopus 로고    scopus 로고
    • June Whitehouse Station, NJ: Merck & Co, Inc. Available at: Accessed September 12, 2011
    • Zostavax: full prescribing information. June 2011. Whitehouse Station, NJ: Merck & Co, Inc. Available at: www.merck.com/product/usa/pi-circulars/z/ zostavax/zostavax-pi2.pdf. Accessed September 12, 2011.
    • (2011) Zostavax: Full Prescribing Information


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.